Total Payments
$1,812
2023 Payments
$13.07
Companies
16
Transactions
138
Medicare Patients
229
Medicare Billing
$97,673
Payment Breakdown by Category
Food & Beverage$1,690 (93.3%)
Education$122.00 (6.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,690 | 112 | 93.3% |
| Education | $122.00 | 26 | 6.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $456.55 | 57 | $0 (2018) |
| Alkermes, Inc. | $355.72 | 13 | $0 (2019) |
| Lundbeck LLC | $227.83 | 14 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $221.47 | 15 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $122.44 | 8 | $0 (2019) |
| Allergan Inc. | $97.99 | 6 | $0 (2019) |
| Vanda Pharmaceuticals Inc. | $81.23 | 6 | $0 (2019) |
| Shire North American Group Inc | $49.80 | 3 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $43.35 | 4 | $0 (2019) |
| Neurocrine Biosciences, Inc. | $37.64 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $13.07 | 1 | AbbVie Inc. ($13.07) |
| 2022 | $14.35 | 1 | Otsuka America Pharmaceutical, Inc. ($14.35) |
| 2019 | $311.46 | 22 | Allergan Inc. ($69.05) |
| 2018 | $407.91 | 44 | Sunovion Pharmaceuticals Inc. ($123.73) |
| 2017 | $1,065 | 70 | Sunovion Pharmaceuticals Inc. ($332.82) |
All Payment Transactions
138 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: Central Nervous System | ||||||
| 08/20/2019 | Tris Pharma Inc | Quillivant XR (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: ADHD | ||||||
| 08/13/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: NEUROLOGY | ||||||
| 08/06/2019 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: PSYCHIATRY | ||||||
| 07/29/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: CNS | ||||||
| 07/09/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), SPRAVATO | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Neuroscience | ||||||
| 06/25/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: Central Nervous System (CNS) | ||||||
| 06/18/2019 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Schizophrenia | ||||||
| 06/11/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: PSYCHIATRY | ||||||
| 05/29/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: NEUROLOGY | ||||||
| 05/14/2019 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Schizophrenia | ||||||
| 05/06/2019 | Lundbeck LLC | BRINTELLIX (Drug) | Food and Beverage | Cash or cash equivalent | $14.73 | General |
| Category: PSYCHIATRY | ||||||
| 04/16/2019 | Lundbeck LLC | BRINTELLIX (Drug) | Food and Beverage | Cash or cash equivalent | $14.73 | General |
| Category: PSYCHIATRY | ||||||
| 03/26/2019 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $13.36 | General |
| Category: PSYCHIATRY | ||||||
| 03/19/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: Central Nervous System | ||||||
| 03/13/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: NEUROSCIENCE | ||||||
| 02/19/2019 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Schizophrenia | ||||||
| 01/15/2019 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: CNS | ||||||
| 01/08/2019 | Allergan Inc. | VRAYLAR (Drug) | Education | In-kind items and services | $29.99 | General |
| Category: NEUROSCIENCE | ||||||
| 01/08/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 21 | 91 | $16,835 | $7,691 |
| 2022 | 1 | 34 | 131 | $23,615 | $10,623 |
| 2021 | 4 | 102 | 415 | $78,775 | $45,683 |
| 2020 | 3 | 72 | 306 | $51,475 | $33,676 |
Total Patients
229
Total Services
943
Medicare Billing
$97,673
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 91 | $16,835 | $7,691 | 45.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 131 | $23,615 | $10,623 | 45.0% |
| 90837 | Psychotherapy, 60 minutes | Office | 2021 | 22 | 241 | $42,000 | $27,845 | 66.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 34 | 125 | $22,150 | $10,892 | 49.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 28 | 29 | $10,725 | $4,323 | 40.3% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2021 | 18 | 20 | $3,900 | $2,622 | 67.2% |
| 90837 | Psychotherapy, 60 minutes | Office | 2020 | 20 | 184 | $28,150 | $21,792 | 77.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 27 | 97 | $14,625 | $8,769 | 60.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 25 | 25 | $8,700 | $3,116 | 35.8% |
About Dr. Charles Dick, MD
Dr. Charles Dick, MD is a Psychiatry healthcare provider based in Rio Grande, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639263882.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Dick, MD has received a total of $1,812 in payments from pharmaceutical and medical device companies, with $13.07 received in 2023. These payments were reported across 138 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,690).
As a Medicare-enrolled provider, Dick has provided services to 229 Medicare beneficiaries, totaling 943 services with total Medicare billing of $97,673. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry
- Location Rio Grande, NJ
- Active Since 10/03/2006
- Last Updated 11/19/2021
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639263882
Products in Payments
- LATUDA (Drug) $445.58
- Aristada 441 mg (Drug) $248.15
- ABILIFY MAINTENA (Drug) $188.93
- INVEGA SUSTENNA (Drug) $122.44
- REXULTI (Drug) $119.39
- TRINTELLIX (Drug) $111.52
- VRAYLAR (Drug) $111.06
- Vivitrol 380 mg (Drug) $79.60
- Fanapt (Drug) $69.94
- Trintellix (Drug) $66.79
- INGREZZA (Drug) $37.64
- SUBOXONE SUBLINGUAL FILM (Drug) $32.04
- VYVANSE (Drug) $31.48
- BRINTELLIX (Drug) $29.46
- AUSTEDO (Drug) $23.30
- MYDAYIS (Drug) $18.32
- VIVITROL (Drug) $14.33
- ARISTADA (Drug) $13.64
- QUILLIVANT XR (Drug) $13.53
- Quillivant XR (Drug) $12.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.